Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/530163 stock hub

BOM/530163 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/530163is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/530163

In the news

Latest news · BOM/530163

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-30.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/530163 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

INR

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	367
Employees Change	-101%
Employees Change Percent	-21.58
Enterprise value	INR 3.8B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 2.9B
Price	INR 225
Price currency	INR
Rev Per Employee	3,470,288.83x
Sic	2834
Symbol	bom/530163
Website	https://www.keralaayurveda.biz

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.06%
EV Earnings	-15.94x
EV/Sales	2.95x
P/B ratio	32.5x
P/S ratio	2.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-21.1%
EBITDA Margin	-19.22%
Gross margin	79.2%
Gross Profit	INR 1B
Gross Profit Growth	-2.37%
Gross Profit Growth Q	12.3%
Gross Profit Growth3 Y	12.68%
Gross Profit Growth5 Y	15.46%
Net Income	INR -235.9M
Pretax Margin	-17.43%
Profit Margin	-18.52%
Profit Per Employee	INR -642,796
Roa5y	1.37
Roe5y	-23.87
ROIC	-30.32
Roic5y	-0.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.35%
Cagr15y	8.09%
Cagr1y	-33.78%
Cagr20y	5.54%
Cagr3y	31.12%
Cagr5y	34.04%
Revenue Growth	1x
Revenue Growth Q	5.89x
Revenue Growth3 Y	11.61x
Revenue Growth5 Y	14.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 49.1M
Debt	INR 845.4M
Debt Equity	INR 9.38
Equity	INR 90.1M
Interest Coverage	-3.69
Net Cash	INR -796.3M
Net Cash By Market Cap	INR -27.19
Net Debt Equity	INR 8.84
Tangible Book Value	INR -116.6M
Tangible Book Value Per Share	INR -13.3
WACC	6.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	282.27%
1Y total return	-33.76%
200-day SMA	350.8
3Y total return	125.46%
50-day SMA	209.8
50-day SMA vs 200-day SMA	50under200
5Y total return	332.53%
All Time High	625
All Time High Change	-63.94%
All Time High Date	2025-07-01
All Time Low	14.85
All Time Low Change	1,417.51%
All Time Low Date	2009-03-23
ATR	13.75
Beta	0.37
Beta1y	1.52
Beta2y	0.97
Ch YTD	-28.63
High	226.7
High52	625
High52 Date	2025-07-01
High52ch	-63.94%
Low	212.6
Low52	150
Low52 Date	2026-03-30
Low52ch	50.23%
Ma50ch	7.39%
Price vs 200-day SMA	-35.76%
RSI	53.48
RSI Monthly	43.03
RSI Weekly	39.44
Sharpe ratio	-0.52x
Sortino ratio	-0.71
Total Return	-3.9%
Tr YTD	-28.63
Tr15y	221.01%
Tr1m	3.56%
Tr1w	8.52%
Tr3m	-9.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -268.8M
Operating margin	-21.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,794,648%
Shares Insiders	12.91%
Shares Institutions	2.35%
Shares Out	12,995,085
Shares Qo Q	37.42%
Shares Yo Y	3.9%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	10,040x
Bv Per Share	6.23
Ch10y	282.3
Ch15y	221
Ch1m	3.56
Ch1w	8.52
Ch1y	-33.76
Ch20y	193.8
Ch3m	-9.79
Ch3y	125.5
Ch5y	332.5
Ch6m	-43.45
Change	4.38%
Change From Open	5.97
Close	215.9
Days Gap	-1.51
Depreciation Amortization	23,998,250
Dollar Volume	2,045,502
Earnings Date	2026-05-26
EBIT	INR -268.8M
EBITDA	INR -244.8M
EPS	INR -19.48
F Score	0
Fiscal Year End	March
Founded	1,945
Income Tax	INR 21M
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Last Split Date	2006-02-13
Last Split Type	Reverse
Ma150	299.6
Ma150ch	-24.78%
Ma20	229.9
Ma20ch	-1.96%
Next Earnings Date	2026-05-26
Open	212.7
Position In Range	90.78
Price Date	2026-05-08
Relative Volume	0.9x
Revenue	1,273,596,000x
Tax By Revenue	1.65x
Tr20y	193.81%
Tr6m	-43.45%
Volume	9,077

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/530163 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/530163 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/530163?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.3%

Share of float held by funds and institutions

Insider ownership

+12.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.9%

Negative means the company is buying back shares.

Technical

BOM/530163 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.5

Neutral momentum band

Price vs 200-day MA

-35.8%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

-0.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/530163

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/530163 stock rating?

bom/530163 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/530163 analysis?

The full report lives at /stocks/bom/530163/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/530163?

The latest report frames bom/530163 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/530163 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.